[1]
Kumar, D.P. and K., R. 2016. Prazolin as a treatment for benign prostatic hypertrophy: a study in a tertiary care centre. International Journal of Basic & Clinical Pharmacology. 5, 3 (Dec. 2016), 639–642. DOI:https://doi.org/10.18203/2319-2003.ijbcp20161111.